BBlogFlow

'Miracle' daughter born after father's cancer news - BBC

·3d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email
Photo credit : Side-by-side photos showing a man in a hospital bed and the same man with a woman and a baby in a swimming pool.

2 days agoPress AssociationLiam was diagnosed with stage four bile duct cancer in April 2025A man who was diagnosed with cancer says his sperm donation one hour before he started chemotherapy led to the birth of his "miracle" daughter. Liam, 38, from Lincoln, was diagnosed with stage four bile duct cancer in April 2025. On the morning he started treatment he donated his sperm for IVF with his partner, Lois. Their daughter Birdie was born in July 2026. Liam said: "If I didn't have Lois and Birdie, I think cancer would control my life. It would dictate what I do hour by hour, minute by minute and I'd constantly be thinking about it. But I've got so many happy distractions in my life that I can take control back. "Liam, who is a former supermarket area manager, started dating Lois in December 2024. In March 2025, he said he was "the fittest" he had ever been when he started experiencing flu-like symptoms. Three days later, he said he noticed a "slight yellow tinge" to his eyeballs and skin, so went to Lincoln County Hospital. Press AssociationBirdie was born in July 2026 A CT scan revealed a stricture in his bile duct.

This article is an excerpt. To read the full content, visit the original source. BBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·